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Abstract The relationship between UCP2 and UCP3 expres-
sion and mitochondrial proton conductance of rat skeletal muscle
was examined. Rats were starved for 24 h and the levels of UCP2
and UCP3 mRNA and UCP3 protein were determined by
Northern and Western blots. Proton conductance was measured
by titrating mitochondrial respiration rate and membrane
potential with malonate. Starvation increased UCP2 and
UCP3 mRNA levels more than 5-fold and 4-fold, respectively,
and UCP3 protein levels by 2-fold. However, proton conductance
remained unchanged. These results suggest either that Northern
and Western blots do not reflect the levels of active protein or
that these UCPs do not catalyse the basal proton conductance in
skeletal muscle mitochondria.
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1. Introduction
Protons ejected from mitochondria during cellular substrate
oxidation return through the ATP synthase, driving ATP syn-
thesis. However, some of the energy is dissipated as protons
return through natural leak pathways [1^3]. Proton leak in rat
skeletal muscle causes 10^15% of basal metabolic rate [2^4],
making it an attractive target for modulation of body mass, as
demonstrated by the successful treatment of obesity in the
1930s using arti¢cial uncoupling by dinitrophenol [5]. The
natural proton leak pathway is unde¢ned, but there are pro-
posals that it is catalysed by uncoupling proteins: UCP1 in
adipose, UCP2 in several tissues, UCP3 in muscle and
BMCP1 and UCP4 in brain [6^12]. There is excellent evidence
that UCP1 uncouples mitochondria in brown adipose tissue,
resulting in facultative thermogenesis [6]. The evidence that
other UCPs uncouple relies mostly on their strong sequence
homology to UCP1; experimental evidence comes only from
expression of exogenous genes in yeast or mammalian cells [7^
14]. Here we monitor natural large changes in expression of
endogenous UCP2 and UCP3 in rat skeletal muscle [13^15]
and show that they are not accompanied by changes in the
basal proton conductance of isolated skeletal muscle mito-
chondria.
2. Materials and methods
2.1. Rat treatments
Female Wistar rats (120 g) were starved for 24 h with free access to
water and compared to paired controls fed ad libitum. The rats were
killed by cervical dislocation. Total hind limb skeletal muscle was
diced, and a random mixture of muscle cubes was frozen in liquid
N2 then used for Northern determination of UCP2 and UCP3
mRNA, and Western determination of UCP3 protein. Mitochondria
were isolated from the remaining tissue [16,17]. Some were used im-
mediately for assay of proton leak; the remainder were stored at 320/
380‡C for Western assay of UCP3.
2.2. Northern blot analysis
Northern blot analysis of UCP2 and UCP3 mRNA was performed
as described elsewhere [18].
2.3. Western blot analysis
Samples were solubilised with SDS, their protein concentration was
determined, then they were subjected to reducing SDS-PAGE. UCP
standards were HEK293-EBNA cells stably transfected with plasmids
mediating inducible expression of hUCP2, hUCP3 or vector. After
blotting to nitrocellulose, UCP3 was detected with a rabbit polyclonal
antibody to a 14 amino acid human UCP3 C-terminal peptide (Chem-
icon #3046, diluted 1:1000 in a skimmed-milk blocking bu¡er), fol-
lowed by goat anti-rabbit horseradish peroxidase-labelled secondary
antibody (Bio-Rad #170-6515, diluted 1:50 000), and developed with
a standard ECL kit (Amersham RPN2106). Chemiluminescence was
detected with a FujiFilm LAS-1000 camera and quanti¢ed with Fuji-
Film Science Lab 97 ImageGauge software. No image enhancing
procedures were used. For quantitation, the linear dynamic range
was s 10. Rat UCP3 signal was normalised to the UCP3/HEK293
signal on the same gel. UCP3 was 5^8-fold enriched in mitochondria
compared to whole muscle. Ab #3046 was speci¢c for UCP3 relative
to UCP2, since it did not cross-react with UCP2 in extracts from
HEK293/UCP2 cells. However, weak interactions with unidenti¢ed
bands were sometimes seen. Another antibody (NN2096B) raised
against a 20 amino acid N-terminal peptide of human and rat
UCP2 did detect human UCP2 in HEK293/UCP2 cells and rat
UCP2 in white fat, but it could not detect UCP2 in rat muscle or
isolated mitochondria, indicating low UCP2 levels in muscle (data not
shown).
2.4. Proton leak measurements
Respiration rate and membrane potential were measured simulta-
neously [19] using electrodes sensitive to oxygen and to the potential-
dependent probe TPMP. Assays contained 0.5 mg of mitochondrial
protein/ml, 120 mM KCl, 5 mM KH2PO4, 3 mM HEPES, 1 mM
EGTA, 2 mM MgCl2 and 0.3% defatted bovine serum albumin
(BSA), pH 7.2. The electrode was calibrated with sequential additions
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up to 2 WM TPMP. 5 WM rotenone, 1 Wg/ml oligomycin, 80 ng/ml
nigericin and 4 mM succinate were added. Malonate was sequentially
added up to 2 mM to change mitochondrial potential. After each run,
0.2 WM FCCP was added to release TPMP for baseline correction.
TPMP binding correction for skeletal muscle was taken to be 0.35 (Wl/
mg protein)31.
3. Results and discussion
UCP2 and UCP3 mRNA were measured by densitometry
of Northern blots and compared to control, fed rats (Figs. 1
and 2). Fig. 2 shows that UCP2 mRNA was more than 5-fold
higher in starved animals than in fed controls, and UCP3
mRNA was more than 4-fold higher, as expected [13^15].
Mitochondria were prepared from the same muscle samples,
and both muscle and mitochondria were assayed for UCP3
protein by Western blotting (Fig. 1). Fig. 2 shows that UCP3
protein in starved animals was double that in fed controls.
We measured the proton conductance of the same mito-
chondria using published protocols [19] in the presence of
BSA to chelate contaminating fatty acids. Fig. 3 shows that
the rate of proton leak across the inner membrane at any
given membrane potential was the same in mitochondria
from starved animals as in mitochondria from fed animals.
We obtained the same result if BSA was omitted from the
medium. When the BSA-containing medium was supple-
mented with 150 WM oleate, state 4 respiration rates increased
by 30%, showing the expected uncoupling e¡ect of fatty acids,
but once again there was no di¡erence in proton leak between
mitochondria from fed and starved animals (not shown).
Thus, starvation increases UCP2 and UCP3 mRNA in
muscle, and UCP3 protein in whole muscle and in muscle
mitochondria, but does not alter the mitochondrial proton
conductance. There are two possible explanations of these
¢ndings. First, UCP3, which is the major UCP in muscle,
catalyses the endogenous proton conductance. However, the
proton leak catalysed by UCP3 does not change when there
are increases in UCP3 mRNA and UCP3 protein as detected
by Western blotting. This could happen if the newly synthe-
Fig. 1. E¡ect of 24 h starvation on UCP3 in rat skeletal muscle. A: Northern blots of UCP3 mRNA in diced muscle. Brown adipose tissue
(BAT) and other skeletal muscle (SM) samples were internal controls. B: Western blots of UCP3 protein in diced muscle. C: Western blots of
UCP3 in isolated mitochondria. Numbers 1^12 indicate di¡erent rats.
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sised UCP3 protein was inactive or ‘masked’ as has been
reported for UCP1 [20], or because of the presence of limiting
amounts of some unknown essential cofactor in our isolated
mitochondrial preparations. This cofactor is not a fatty acid
such as oleate, since addition of oleate or removal of BSA did
not a¡ect the results. We should point out that there is no
evidence for ‘masking’ or for any other cofactor of UCP3.
Similar arguments apply to UCP2, but we have not measured
UCP2 protein so cannot be sure that it changes when UCP2
mRNA increases. The second, simpler explanation is that
UCP3 (and UCP2) do not catalyse the basal proton conduc-
tance of muscle mitochondria that we measure in our stand-
ard assay, but have some other function.
Several reports support a lack of correlation between UCP2
or UCP3 mRNA levels and mitochondrial proton conduc-
tance.
1. Tissue levels of UCP2 and UCP3 mRNA correlate better
with regulation of lipids as fuel substrates than with ther-
mogenesis [18,21] : they rise in muscle of food-deprived
rats, when this tissue is thermogenically depressed [22].
Heat production from soleus muscle did not increase above
basal in starved mice despite a 5-fold increase in UCP3
mRNA content [13].
2. In brown adipose tissue mitochondria from UCP1 knock-
out mice, UCP2 mRNA increased 5-fold, but basal proton
conductance did not change [23,24].
3. UCP3 mRNA was increased in skeletal muscle from hyper-
thyroid compared to hypothyroid rats [25]. However, in the
presence of bovine serum albumin (which should always be
present, to prevent fatty acid-mediated uncoupling through
other pathways such as the adenine nucleotide transporter)
the muscle mitochondria showed ‘no clear cut change in
proton leak kinetics’. Thus the basal proton leak varied
little despite 25-fold changes in UCP3 mRNA.
4. No UCP homologues have been found in hepatocytes from
normal adult rats [26], but hepatocyte mitochondria have
normal basal proton conductance [1,2].
5. Clear UCP homologues are absent from the genomes of
yeast (Saccharomyces cerevisiae) despite normal basal pro-
ton conductance [2,3], and the nematode Caenorhabditis
elegans [3], the only fully sequenced multicellular organism.
However, UCP2 is present in ectothermic vertebrates (carp
and zebra¢sh), implying that it has functions other than
thermogenesis [27].
6. Observed changes in UCP2 or UCP3 mRNA are fre-
quently opposite to the ones expected if the proteins are
involved in proton conductance and thermogenesis, e.g.
[28]. Clever secondary hypotheses may explain the appar-
ent anomaly, but the simplest explanation is that UCP2
and UCP3 do not catalyse the proton leak. Sometimes
the changes are as expected, but the presence of a correla-
tion in some cases is less persuasive than the absence of a
correlation in others.
In our system, there are large changes in UCP2 mRNA and
UCP3 mRNA in muscle, but no change in mitochondrial
proton conductance. Therefore, it is unsafe in any system to
assume that mitochondrial proton leak will change based only
on the observation that UCP2 or UCP3 mRNA levels change,
despite numerous examples of this inference in the literature.
We ¢nd that UCP3 protein level changes too, so we conclude
that it is unsafe in any system to infer changes in mitochon-
drial proton permeability even from changes in Western meas-
urements of UCP3 protein. The proton conductance that we
measure with our standard assay is a major contributor to
basal metabolic rate, but it does not change when UCP2
and UCP3 mRNA and UCP3 protein levels change. Our evi-
dence therefore suggests that these UCPs do not catalyse the
observed basal proton conductance in isolated skeletal muscle
mitochondria. UCP1 catalyses an inducible proton conduc-
tance in brown adipose tissue mitochondria. In principle,
UCP2 or UCP3 could catalyse such an additional inducible
proton conductance in skeletal muscle, but there is no evi-
dence in native expression systems that this is the case, and
Fig. 2. Quantitative e¡ect of 24 h starvation on UCP2 and UCP3
in rat skeletal muscle. Northern blots for UCP2 and UCP3 mRNA
and Western blots for UCP3 protein were quanti¢ed and are shown
as percentage of fed control. Data are mean þ S.E.M. for three ex-
periments. Signi¢cances were determined using an unpaired t-test
for mRNA and weighted ANOVA for protein. *P6 0.05;
**P6 0.01; ***P6 0.001.
Fig. 3. Kinetic response of proton leak to potential in skeletal
muscle mitochondria from control (open circles) and 24 h starved
rats (closed circles). Data are mean þ S.E.M. of three experiments
done in triplicate.
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no evidence for it in our experiments using skeletal muscle
from starved rats.
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